Domain Therapeutics enters into collaboration with XOMA
DTect-All(TM) platform will be used to screen for GPCR-directed allosteric…
4 February 2014 | By Domain Therapeutics
DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies...